Clinical Roundup Antibody-drug conjugate targeting CEACAM5 shows activity in advanced CRC in phase I study preliminary data June 07, 2024Vol.50 No.23
Clinical Roundup USP1 inhibitor combination shows manageable safety profile, anti-tumor activity in metastatic solid tumors in phase I study preliminary data June 07, 2024Vol.50 No.23
Clinical Roundup CM24 combination improves clinical outcomes in advanced metastatic PDAC in phase II study interim data June 07, 2024Vol.50 No.23
Clinical Roundup Studies detail molecular pathway that impacts pancreatic cancer progression and response to treatment June 07, 2024Vol.50 No.23
Clinical Roundup LGBTQ+ cancer report reveals unique stressors, discrimination likely to increase cancer risk May 31, 2024Vol.50 No.22
Clinical Roundup Degradation of HER2, EGFR may overcome drug resistance in HER2-positive breast cancers May 31, 2024Vol.50 No.22
Clinical Roundup PKMYT1 is a potential target for treatment-resistant ER+ breast cancers May 31, 2024Vol.50 No.22
Clinical Roundup Circadian clock can be leveraged to enhance cancer immunotherapy May 31, 2024Vol.50 No.22
Clinical Roundup Keytruda improves OS for high-risk early-stage TNBC in phase III trial May 31, 2024Vol.50 No.22
